Syngene had guided for revenue growth to be in the early teens, while margins to moderate from current levels. Previous Post Natco Pharma to buy 35.75% stake in Adcock Ingram Holdings for ₹2,000 crore Next Post Westlife Foodworld Q1 Results: McDonald’s operator profit drops 63% hit by depreciation costs Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
